YOLFTbeta
Lotus Pharmaceutical Co Ltd

Lotus Pharmaceutical Co Ltd

1795 · TW · Healthcare / Drug Manufacturers - Specialty & Generic

141.50TWD-14.50 (-9.29%)

Price History

Full chart

Market Stats

Previous Close156.00
Open152.00
Day Range140.50 – 153.00
52-Week Range170.50 – 369.50
Volume6.06M
Market Cap46.96B
P/E (TTM)12.42
Forward P/E0.00
EPS14.21
Dividend Yield1.45%
Beta0.65
50-Day Avg181.92
200-Day Avg224.37

About

Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, central nervous system, cardiovascular diseases, woman health, and anti-obesity. The company also engages in retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical products; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. In addition, it offers management consultancy services; pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Petar Antonov Vazharov
  • Employees0
  • HeadquartersNo. 277 Song Ren Road, Taipei, Taiwan, 110, Taiwan
  • Websitehttps://www.lotuspharm.com.tw

Leadership

  • Mr. Petar Antonov VazharovCEO & Representative Director
  • Ms. Gwen HsiehChief Information Officer
  • Mr. Bjartur ShenVice President of Strategies & Finance
  • Ms. Eeling Chan CPAChief Financial Officer
  • Mr. Vamsi Kiran KosarajuChief Operations Officer
  • Yi Ling TianAccounting Supervisor
  • Venkata Rama Prasad YarasaniChief Scientifics Officer
  • Mr. Jeffrey TsangHead of Investor Relations & Corporate Communications
  • Mr. Edin BuljubasicVice President of Legal and Compliance
  • Ms. Fiona LeiHead of Human Resources

Financials

Income Statement

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue606.82M590.18M532.21M503.15M658.48M2.31B5.52B5.90B6.42B6.43B9.17B10.73B12.65B14.63B16.96B18.58B20.51B
Growth (%)--2.74%-9.82%-5.46%+30.87%+250.81%+139.04%+6.89%+8.83%+0.08%+42.71%+16.94%+17.90%+15.68%+15.89%+9.59%+10.36%
Cost of Revenue248.43M235.66M204.71M228.22M249.40M1.16B2.29B2.57B3.34B3.29B4.93B6.13B7.01B6.83B7.57B7.66B9.87B
Gross Profit358.40M354.52M327.50M274.94M409.08M1.15B3.23B3.33B3.08B3.14B4.25B4.60B5.64B7.81B9.38B10.92B10.64B
Gross Margin59.06%60.07%61.54%54.64%62.13%49.99%58.47%56.38%47.94%48.83%46.30%42.84%44.59%53.35%55.34%58.78%51.86%
Operating Expense318.02M331.76M473.36M478.35M434.37M1.59B2.78B3.08B2.56B2.69B3.03B2.96B3.44B3.49B4.48B4.91B4.74B
Operating Income40.38M22.76M-145.87M-203.41M-25.29M-435.25M448.84M244.38M523.09M448.69M1.22B1.64B2.20B4.32B4.90B6.02B5.90B
Operating Margin6.65%3.86%-27.41%-40.43%-3.84%-18.84%8.13%4.14%8.14%6.98%13.25%15.26%17.40%29.52%28.91%32.38%28.75%
EBITDA51.37M69.44M21.59M-135.44M98.92M-338.49M960.37M592.08M856.08M874.97M1.92B2.34B2.93B5.26B6.87B8.21B7.44B
EBITDA Margin8.46%11.77%4.06%-26.92%15.02%-14.65%17.39%10.03%13.33%13.61%20.92%21.85%23.13%35.94%40.52%44.20%36.27%
Net Income3.12M15.05M-38.40M-193.23M11.88M-442.13M103.95M-134.04M7.68M99.48M662.81M1.03B1.40B3.02B4.11B5.07B4.72B
Net Income Margin0.51%2.55%-7.22%-38.40%1.80%-19.14%1.88%-2.27%0.12%1.55%7.22%9.57%11.09%20.64%24.21%27.26%23.01%
R&D93.91M96.80M237.92M231.93M190.23M131.97M298.72M452.18M329.52M324.94M553.57M505.38M595.92M520.45M720.83M773.89M986.71M
R&D as % of Total Revenue15.48%16.40%44.70%46.10%28.89%5.71%5.41%7.66%5.13%5.05%6.03%4.71%4.71%3.56%4.25%4.16%4.81%
Interest Expense1.24M4.04M8.93M10.36M6.14M86.74M359.61M277.90M259.66M320.01M350.36M333.78M296.84M382.46M557.40M570.76M894.48M
Interest Expense % of Total Revenue0.20%0.69%1.68%2.06%0.93%3.76%6.51%4.71%4.04%4.98%3.82%3.11%2.35%2.61%3.29%3.07%4.36%

Balance Sheet

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets706.92M1.14B1.12B1.09B2.00B16.27B15.50B15.24B15.66B14.85B17.92B19.75B21.22B29.53B32.99B40.10B106.15B
Total Liabilities250.19M493.75M524.73M447.79M512.97M7.46B6.77B6.88B7.96B7.17B10.17B11.01B10.15B15.66B15.66B18.92B82.37B
Total Equity456.73M646.95M596.05M637.28M1.49B7.91B7.80B7.44B7.29B7.23B7.74B8.75B11.07B13.87B17.33B21.18B23.78B
Cash110.59M469.68M191.99M190.88M1.01B1.10B1.58B2.02B1.77B1.02B1.12B1.49B1.61B1.98B1.77B6.03B7.74B
Total Debt57.64M319.86M9.78M123.80M367.64M4.20B4.55B4.93B5.29B2.07B4.93B5.47B6.39B8.92B11.58B13.67B55.93B
Net Debt-52.95M-149.82M-182.21M-67.08M-642.25M3.11B2.98B2.91B3.52B1.05B3.81B3.99B4.78B6.93B9.81B7.64B48.19B

Cash Flow

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow89.50M59.19M-76.29M-54.45M-95.84M-1.03B1.08B1.23B592.29M796.98M302.81M1.95B119.66M3.72B1.61B6.15B7.48B
Investing Cash Flow-29.82M-142.96M-189.09M-106.74M-13.45M-4.72B-191.02M-577.12M-908.61M-498.34M-2.39B-1.12B-1.58B-4.66B-3.25B-2.69B-12.47B
Financing Cash Flow-15.57M443.76M-14.29M157.95M926.73M5.53B-381.13M-151.12M18.16M-958.13M2.23B-545.31M1.66B1.26B1.40B714.09M6.90B
Capital Expenditure25.17M147.57M187.90M80.91M33.47M222.89M520.71M660.48M914.84M399.07M1.10B2.00B1.62B577.16M3.28B1.47B4.35B
Free Cash Flow64.33M-88.38M-264.19M-135.36M-129.31M-1.26B556.86M572.52M-322.55M397.91M-799.90M-48.86M-1.50B650.03M-1.65B4.69B3.13B
Dividends Paid6.90M4.08M13.37M145.00M-----92.00M92.00M92.00M92.00M506.06M906.23M1.23B1.52B
FCF to OCF71.88%-149.31%346.28%248.59%134.93%121.59%51.68%46.43%-54.46%49.93%-264.16%-2.51%-1250.26%17.48%-102.27%76.19%41.79%
Dividend Paid to FCF10.72%-4.61%-5.06%-107.12%-----23.12%-11.50%-188.31%-6.15%77.85%-54.90%26.27%48.60%

Earnings

Report DateAug 12, 2013Nov 8, 2013Mar 27, 2014May 14, 2014May 16, 2017Aug 14, 2017Mar 15, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Mar 27, 2019May 15, 2019Aug 14, 2019Nov 13, 2019Mar 19, 2020May 15, 2020Aug 14, 2020Nov 13, 2020Mar 29, 2021May 16, 2021Aug 12, 2021Nov 10, 2021Mar 22, 2022May 13, 2022Aug 12, 2022Nov 10, 2022Mar 9, 2023May 14, 2023Aug 10, 2023Nov 9, 2023Mar 14, 2024May 10, 2024Aug 7, 2024Nov 6, 2024Mar 6, 2025May 8, 2025Aug 13, 2025Nov 13, 2025Mar 14, 2026Mar 31, 2026Aug 13, 2026
EPS Estimate-0.15-0.36-0.12-0.120.370.370.480.120.210.220.241.200.971.131.620.621.231.221.201.681.811.551.171.431.205.871.173.033.974.621.434.095.256.013.343.855.174.445.762.712.30
EPS Actual-0.110.08-0.27-0.69-0.300.15-0.020.07-0.230.280.311.150.200.810.570.531.211.141.311.821.361.310.961.691.237.830.634.494.784.701.513.895.025.904.325.402.755.464.261.972.43
Surprise26.67%122.22%-125.00%-475.00%-181.08%-59.46%-104.17%-41.67%-209.52%27.27%29.17%-4.17%-79.38%-28.32%-64.81%-14.52%-1.63%-6.56%9.17%8.33%-24.86%-15.48%-17.95%18.18%2.50%33.39%-46.15%48.18%20.40%1.73%5.59%-4.89%-4.38%-1.83%29.34%40.26%-46.81%22.97%-26.04%-27.27%5.65%
TimingPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hours-After-hours

Key Statistics & Ratios

Market Cap46.96B
Enterprise Value90.71B
Trailing P/E12.42
Forward P/E0.00
Price / Sales1.65
Price / Book1.94
EPS14.21
Book Value90.12
Revenue (TTM)28.49B
Gross Profit (TTM)15.31B
EBITDA9.20B
Profit Margin13.22%
Operating Margin26.49%
Return on Equity16.86%
Return on Assets6.20%
Shares Outstanding266.04M
Shares Float137.49M
Beta0.65
Dividend Yield1.45%
Dividend Rate2.57
Payout Ratio40.15%

Dividends

20231×
3.46Jul 5, 2023
20221×
1.93Aug 4, 2022
20211×
0.35Jul 7, 2021